US Broker Ratings

Encompass Health Corporation (EHC) Stock Analysis: A Promising 13% Upside Potential for Investors

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, specializes in providing post-acute healthcare services across the United States and Puerto Rico. With a market capitalization of..

BeOne Medicines Ltd. (ONC) Stock Analysis: Exploring a 19% Potential Upside in the Biotech Sector

BeOne Medicines Ltd. (ONC), a Swiss-based biotechnology firm, has captured investor attention with a promising potential upside of 19.05%, according to analyst ratings. With a market capitalization of $37.79 billion..

CVS Health Corporation (CVS) Stock Analysis: Navigating Healthcare Growth with a 7.56% Upside Potential

CVS Health Corporation (NYSE: CVS) stands as a titan in the healthcare sector, offering comprehensive health solutions through its diverse operational segments: Health Care Benefits, Health Services, and Pharmacy &..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating a 20% Potential Upside Amidst a Robust Dividend Yield

For investors eyeing opportunities in the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents an intriguing proposition. With a market capitalization of $89.48 billion, this pharmaceutical giant is a key..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating the Healthcare Sector with a 10.65% Upside Potential

Fresenius Medical Care AG (NYSE: FMS), a global leader in providing dialysis and related services, stands at a pivotal moment for investors. As the world’s largest provider of dialysis products..

Solventum Corporation (SOLV) Stock Analysis: Unpacking a 20.69% Potential Upside in the Healthcare Sector

Solventum Corporation (NYSE: SOLV) is a burgeoning healthcare entity that has been drawing attention with its impressive market presence in the medical instruments and supplies industry. With a market capitalization..

Novo Nordisk A/S (NVO) Stock Analysis: A Healthcare Giant with a Strong Dividend Yield and Significant Upside

Novo Nordisk A/S, a towering presence in the healthcare sector, continues to capture investor attention with its robust dividend yield and potential for significant upside. As a leading player in..

Walgreens Boots Alliance (WBA) Stock Analysis: High Dividend Yield Amidst Financial Challenges

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a stalwart in the healthcare and pharmaceutical retail sector, is navigating a complex financial landscape that presents both opportunities and challenges for investors. With..

Revvity, Inc. (RVTY) Stock Analysis: Exploring 30% Potential Upside in the Healthcare Diagnostics Sector

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, offers an intriguing investment opportunity with a compelling potential upside of 30.33%, according to recent analyst ratings. Formerly known as..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a Potential 11.64% Upside in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture the attention of investors with its robust portfolio of medical supplies and diagnostic products. With..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotech Leader with a Robust Pipeline and Strong Buy Ratings

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a prominent player in the biotechnology sector, continues to capture investor attention with its innovative approach to therapeutics based on ribonucleic acid interference (RNAi). With..

Thermo Fisher Scientific (TMO) Stock Analysis: A 5.59% Upside Potential in Healthcare Diagnostics

Thermo Fisher Scientific Inc. (NYSE: TMO), a titan in the diagnostics and research industry within the healthcare sector, stands as a beacon of innovation and reliability. With a market capitalization..

Zimmer Biomet Holdings (ZBH) Investor Outlook: Exploring a Potential 16.72% Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the healthcare sector, is making waves in the medical devices industry. With a market capitalization of $18.76 billion, the company continues..

Labcorp Holdings Inc. (LH) Stock Analysis: Revenue Growth and Analyst Consensus Signal Potential Upside

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors seeking exposure to the evolving landscape of..

Illumina, Inc. (ILMN) Stock Analysis: Exploring a Potential 18.82% Upside in Genomic Innovation

Illumina, Inc. (NASDAQ: ILMN), a leader in the genomics industry, offers intriguing prospects for investors willing to navigate the dynamic healthcare sector. With a market capitalization of $14.43 billion, Illumina..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating the Healthcare Sector with Strategic Growth

Molina Healthcare Inc (MOH), a key player in the healthcare plans industry, is an intriguing prospect for investors seeking exposure to the healthcare sector. With a market capitalization of $10.52..

BioNTech SE (BNTX) Stock Analysis: Evaluating a 31.78% Potential Upside for Forward-Thinking Investors

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has been making headlines with its innovative approaches to cancer and infectious disease treatments. Based in Mainz, Germany, the..

Haleon plc (HLN) Stock Analysis: Unpacking a 29% Potential Upside in Healthcare’s Promising Player

Investors with a keen eye on the healthcare sector may find Haleon plc (HLN) a compelling consideration, especially with its notable 29.33% potential upside. As a prominent player in the..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 21.94% Potential Upside

As investors scour the healthcare sector for promising opportunities, Koninklijke Philips N.V. (NYSE: PHG) stands out with its substantial market capitalization of $26.88 billion and a notable potential upside of..

Insmed Incorporated (INSM) Stock Analysis: Biotechnology Growth with a 3.28% Potential Upside

Insmed Incorporated (NASDAQ: INSM) stands as a prominent player in the biotechnology sector, commanding attention with its cutting-edge therapies targeting serious and rare diseases. With its headquarters in Bridgewater, New..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds